mevalonic acid has been researched along with Neoplasm Metastasis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartella, L; Cappello, AR; Di Donna, L; Dolce, V; Fiorillo, M; Lisanti, MP; Peiris-Pagès, M; Sanchez-Alvarez, R; Sindona, G; Sotgia, F | 1 |
| Chen, H; Fang, X; Huang, L; Jiang, Y; Li, N; Liu, Y; Mei, L; Sun, S; Wang, H; Wang, Z; Wu, Y; Zhang, F; Zhang, X; Zhang, Y; Zheng, Y | 1 |
| Garnett, DJ | 1 |
| Fukuda, M; Handa, H; Hashimoto, A; Hashimoto, S; Nam, JM; Oikawa, T; Okada, M; Oneyama, C; Onodera, Y; Otsuka, Y; Sabe, H; Sugino, H; Yoshikawa, A | 1 |
| Assaraf, YG; Bieńk, K; Cieślar-Pobuda, A; Dutta, C; Ghavami, S; Likus, W; Pakuła, M; Pathak, H; Shojaei, S; Siemianowicz, K; Wang, Q; Łos, MJ | 1 |
| Chiarugi, P; Comito, G; Giannoni, E; Lanciotti, M; Morandi, A; Pons Segura, C; Serni, S; Taddei, ML | 1 |
| Iguchi, K | 1 |
| Hirano, K; Iguchi, K; Nakano, T; Usui, S | 1 |
| Altundag, K; Bulut, N; Dincer, M; Harputluoglu, H | 1 |
| Chellaiah, MA; Desai, B; Rogers, MJ | 1 |
| Kim, BS; Kim, TS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Yoo, NC | 1 |
2 review(s) available for mevalonic acid and Neoplasm Metastasis
| Article | Year |
|---|---|
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Topics: Animals; Antineoplastic Agents; Disease Progression; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasms; Neoplastic Stem Cells; Proto-Oncogene Mas | 2016 |
[Effect of bisphosphonates on anticancer activity in prostate cancer cells].
Topics: Antineoplastic Agents; Apoptosis; Diphosphonates; Humans; Male; Mevalonic Acid; Neoplasm Metastasis; Prostatic Neoplasms; Tumor Cells, Cultured | 2012 |
9 other study(ies) available for mevalonic acid and Neoplasm Metastasis
| Article | Year |
|---|---|
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism.
Topics: Apoptosis; Biological Products; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl CoA Reductases; Mevalonic Acid; Mitochondria; Neoplasm Metastasis; Neoplastic Stem Cells; Plant Oils; Prognosis; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Signal Transduction; Survival Rate | 2018 |
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
Topics: Actins; Adaptor Proteins, Signal Transducing; Animals; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hippo Signaling Pathway; Humans; Hyaluronan Receptors; Mevalonic Acid; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Transplantation; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Simvastatin; Transcription Factors; YAP-Signaling Proteins | 2014 |
Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Caveolae; Caveolin 1; Cell Line, Tumor; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Mevalonic Acid; Neoplasm Metastasis; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Phenotype; Proadifen | 2016 |
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; gamma-Glutamyltransferase; HEK293 Cells; Humans; MCF-7 Cells; Mevalonic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; rab GTP-Binding Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Topics: Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Movement; Diphosphonates; Humans; Imidazoles; Macrophage Activation; Macrophages; Male; Mevalonic Acid; Neoplasm Metastasis; Neovascularization, Pathologic; Phenotype; Prostatic Neoplasms; rhoA GTP-Binding Protein; Stromal Cells; Tumor Microenvironment; Zoledronic Acid | 2017 |
Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Topics: Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Cytosol; Diphosphonates; Enzyme Inhibitors; Humans; Leucine; Male; Mevalonic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; rap1 GTP-Binding Proteins | 2006 |
Statins may decrease skeletal-related events in breast cancer patients with bone metastases.
Topics: Acyl Coenzyme A; Apoptosis; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cell Division; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Neoplasm Metastasis; Osteoclasts | 2006 |
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Topics: Adenocarcinoma; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Diphosphonates; Enzyme Activation; Giant Cells; Humans; Hyaluronan Receptors; Integrin alphaVbeta3; Male; Matrix Metalloproteinase 9; Mevalonic Acid; Mutant Proteins; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Osteopontin; Prostatic Neoplasms; Protein Prenylation; RANK Ligand; Recombinant Fusion Proteins; rho GTP-Binding Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction | 2007 |
Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.
Topics: Anticoagulants; Antineoplastic Agents; Carrier Proteins; Cell Adhesion; Cell Division; Cell Movement; Cytokines; Doxorubicin; Drug Synergism; Gelatinases; Humans; Lovastatin; Matrix Metalloproteinase 2; Metalloendopeptidases; Mevalonic Acid; Midkine; Neoplasm Metastasis; Pentosan Sulfuric Polyester; Peptide Hydrolases; Phenotype; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Stomach Neoplasms; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1999 |